Our primary goal is to make life-changing, long-term differences in human health and disease management through the products and services we provide. The patients and professionals who rely on our products place their trust in the reliability of our clinical research, the rigor of our scientific publications, the independence of professional education we fund and the integrity of our relationships with health care professionals.
Our companies work to prevent real or perceived conflicts of interest that may arise from relationships between companies and health care professionals. Consistent with our ongoing commitment to ensure ethical and transparent interactions with medical professionals, we regularly review and update our practices that guide interactions with health care professionals, institutions and other stakeholders in the health care system.
Funding to Health Care Professionals
We believe in greater transparency regarding the relationships between health care companies and physicians. We are committed to begin voluntarily disclosing payments made to physicians by its U.S. pharmaceutical and medical device and diagnostics companies.
Johnson & Johnson was one of the first large health care companies to support the Physician Payments Sunshine Act, which was incorporated into the federal Patient Protection and Affordable Care Act of 2009. On June 30, 2010, our U.S. commericial pharmaceuticals companies began voluntarily disclosing payments made to physicians during the first quarter of 2010. Under the Patient Protection and Affordable Care Act, this type of disclosure is not required until 2013.
Listed below are the links to these reports from the various Pharmaceutical and Medical Device & Diagnostics operating companies within the Johnson & Johnson Family of Companies.
Pharmaceutical Companies
Medical Device & Diagnostics
Clinical Trial Registration and Results
We post results of controlled clinical studies, regardless of their outcomes, online at ClinicalTrials.gov. Our researchers are committed to publishing results that are scientifically or medically important, including results that affect the registration or utilization of a Company product, as well as results from discontinued clinical research.
For more information:
ClinicalTrials.gov
Funding for Professional Education
We recognize our responsibility to support health care professionals in their pursuit of current education so they may provide the best patient care possible. Our Pharmaceutical and Medical Device & Diagnostics companies in the U.S. disclose the nature and volume of grants they make for professional education.
Listed below are the links to these reports from the various Pharmaceutical and Medical Device & Diagnostics operating companies within the Johnson & Johnson Family of Companies.
Pharmaceutical Companies
Medical Device & Diagnostics
Charitable Giving
Our giving focuses on making life changing, lasting differences in the health of people who do not have access to medicine or quality medical care. Our Pharmaceutical and Medical Device & Diagnostics companies in the U.S. provide information on the contributions they make to charitable organizations in the health care field.
Listed below are the links to these reports from the various Pharmaceutical and Medical Device & Diagnostics operating companies within the Johnson & Johnson Family of Companies.
Pharmaceutical Companies
Medical Device & Diagnostics
Sustainability Goals and Reporting
Our long-term environmental goals serve as a roadmap for Johnson & Johnson to becoming one of the most environmentally responsible companies in the world. We report our progress each year in a Sustainability Report that covers environmental goals, business and social performance and charitable programs.
Additional information about our business values:
Responsibility Site
Accountable Business Practices